Tarsus posts $194.6 million in XDEMVY sales, advances four-drug pipelineNov 3Quarterly updatelotilanerlotilaner ophthalmic solution
Tarsus files 8-K confirming closed terms of Alkeus acquisition and Stargardt drug rightsSep 10M&ATarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals prices $125 million private placement financingAug 6FinancingTarsus Pharmaceuticals, Inc.
Tarsus posts record XDEMVY sales, raises guidance, moves to acquire AlkeusAug 6Quarterly updatelotilaner ophthalmic solutionTarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals' chief commercial officer to depart July 15Jul 13PeopleTarsus Pharmaceuticals, Inc.
Tarsus acquires iRenix Medical for up to $565 million to add late-stage eye drug IRX-101Jul 8M&ATarsus Pharmaceuticals, Inc.